2022 rdca-dap workshop: case study 3, duchenne regulatory science consortia (d-rsc)
Published 2 years ago • 223 plays • Length 24:22Download video MP4
Download video MP3
Similar videos
-
53:16
2022 rdca-dap workshop: case studies panel discussion and q&a
-
1:16:37
2022 rdca-dap workshop: future of rdca-dap and the patient voice
-
11:26
2022 rdca-dap workshop: case study 2, critical path for sickle cell disease consortium (cp-scd)
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
26:47
2022 rdca-dap workshop: centrality of patient advocacy organizations in accelerating treatments
-
15:20
2022 rdca-dap workshop: keynote
-
7:01
2022 rdca-dap workshop: opening remarks
-
11:04
iq test - 20 real iq test questions
-
7:20
ermp recall clinical case discussion - case 22- steps in dka treatment
-
7:11
case study on dmdd in urdu/hindi | disruptive mood dysregulation disorder.
-
41:33
2022 rdca-dap workshop: new collaborations for rdca-dap
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
1:19:08
2022 rdca-dap workshop: impact of rdca-dap panel discussion
-
12:03
rdca-dap drug development tool prototypes
-
58:49
webinar: how rdca-dap can help inform optimal trial design in progressive rare disease
-
25:53
2021 rdca-dap annual workshop: examples of multiple datasets shared within one disease group
-
57:16
2021 rdca-dap annual workshop: optimization of a clinical scale for use as a regulatory endpoint (2)
-
1:25:50
rdca-dap launch live stream - pm part 1
-
6:01
2022 rdca-dap workshop: closing remarks
-
21:20
2021 rdca-dap annual workshop: optimization of a clinical scale for use as a regulatory endpoint (1)
-
8:10
do you think the community will work together to share data, or do you anticipate resistance?